Paper41009719
Mechanisms and Therapeutic Perspectives of Podocyte Aging in Podocytopathies.
Ma SJ and 3 others. Int J Mol Sci, 2025. Cited by 5 papers, by iCite.
Cite this record
ConductScience Library. Mechanisms and Therapeutic Perspectives of Podocyte Aging in Podocytopathies. Papers, record 41009719. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41009719
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Podocytes | Major topic |
| Cellular Senescence | Major topic |
| Kidney Diseases | Major topic |
| Humans | |
| Animals | |
| Autophagy | |
| Aging |
Source PubMed
Grants8
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 82370728 | National Natural Science Foundation of China | PubMed | ||
| 82470771 | National Natural Science Foundation of China | PubMed | ||
| 82200841 | National Natural Science Foundation of China | PubMed | ||
| 81974097 | National Natural Science Foundation of China | PubMed | ||
| 2024YFC3044900 | National Key Research and Development Program of China | PubMed | ||
| 2023BCB034 | Key Research and Development Program of Hubei Province | PubMed | ||
| 2024AFD083 | the Innovation and Development Joint Fund of Enshi | PubMed | ||
| 2024HBBHCXB028 | Hubei Province Postdoctoral Innovative Talent Training Program | PubMed |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Erratum in | 42884184 | Correction: Ma et al. Mechanisms and Therapeutic Perspectives of Podocyte Aging in Podocytopathies. Int. J. Mol. Sci. 2025, 26, 9159. | https://conductscience.org/library/papers/42884184 |
Source PubMed
References192
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36263181 | Regulation of Podocyte Injury by CircHIPK3/FUS Complex in Diabetic Kidney Disease. | Int J Biol Sci | 2022 | https://conductscience.org/library/papers/36263181 | PubMed |
| 2 | 26039325 | Endothelial cell and podocyte autophagy synergistically protect from diabetes-induced glomerulosclerosis. | Autophagy | 2015 | https://conductscience.org/library/papers/26039325 | PubMed |
| 3 | 33850550 | Metformin attenuates diabetic renal injury via the AMPK-autophagy axis. | Exp Ther Med | 2021 | https://conductscience.org/library/papers/33850550 | PubMed |
| 4 | 37900001 | Therapeutic Potential Targeting Podocyte Mitochondrial Dysfunction in Focal Segmental Glomerulosclerosis. | Kidney Dis (Basel) | 2023 | https://conductscience.org/library/papers/37900001 | PubMed |
| 5 | 37507049 | Deletion of protein tyrosine phosphatase SHP-1 restores SUMOylation of podocin and reverses the progression of diabetic kidney disease. | Kidney Int | 2023 | https://conductscience.org/library/papers/37507049 | PubMed |
| 6 | 33754024 | GPR43 deficiency protects against podocyte insulin resistance in diabetic nephropathy through the restoration of AMPKα activity. | Theranostics | 2021 | https://conductscience.org/library/papers/33754024 | PubMed |
| 7 | 22301996 | (Pro)renin receptor and autophagy in podocytes. | Autophagy | 2012 | https://conductscience.org/library/papers/22301996 | PubMed |
| 8 | 31040292 | FHL2 mediates podocyte Rac1 activation and foot process effacement in hypertensive nephropathy. | Sci Rep | 2019 | https://conductscience.org/library/papers/31040292 | PubMed |
| 9 | 28819100 | Blockage of the lysosome-dependent autophagic pathway contributes to complement membrane attack complex-induced podocyte injury in idiopathic membranous nephropathy. | Sci Rep | 2017 | https://conductscience.org/library/papers/28819100 | PubMed |
| 10 | 23691056 | Dysregulated autophagy contributes to podocyte damage in Fabry's disease. | PLoS One | 2013 | https://conductscience.org/library/papers/23691056 | PubMed |
| 11 | 34163041 | Senolytics for kidney repair. | Nat Rev Nephrol | 2021 | https://conductscience.org/library/papers/34163041 | PubMed |
| 12 | 32792490 | Podocytopathies. | Nat Rev Dis Primers | 2020 | https://conductscience.org/library/papers/32792490 | PubMed |
| 13 | 33321755 | Metformin Protects against Podocyte Injury in Diabetic Kidney Disease. | Pharmaceuticals (Basel) | 2020 | https://conductscience.org/library/papers/33321755 | PubMed |
| 14 | 31420196 | Podocyte development, disease, and stem cell research. | Kidney Int | 2019 | https://conductscience.org/library/papers/31420196 | PubMed |
| 15 | 36531996 | Canagliflozin reverses Th1/Th2 imbalance and promotes podocyte autophagy in rats with membranous nephropathy. | Front Immunol | 2022 | https://conductscience.org/library/papers/36531996 | PubMed |
| 16 | 38504059 | Obesity-related glomerulopathy is associated with elevated WT1 expression in podocytes. | Int J Obes (Lond) | 2024 | https://conductscience.org/library/papers/38504059 | PubMed |
| 17 | 28905451 | Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development. | Stem Cells | 2017 | https://conductscience.org/library/papers/28905451 | PubMed |
| 18 | 35918536 | Biochemical and mechanical regulation of actin dynamics. | Nat Rev Mol Cell Biol | 2022 | https://conductscience.org/library/papers/35918536 | PubMed |
| 19 | 34363464 | Role of Cellular Senescence in Type II Diabetes. | Endocrinology | 2021 | https://conductscience.org/library/papers/34363464 | PubMed |
| 20 | 35716094 | A critical role of the podocyte cytoskeleton in the pathogenesis of glomerular proteinuria and autoimmune podocytopathies. | Acta Physiol (Oxf) | 2022 | https://conductscience.org/library/papers/35716094 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42884184 | Correction: Ma et al. Mechanisms and Therapeutic Perspectives of Podocyte Aging in Podocytopathies. Int. J. Mol. Sci. 2025, 26, 9159. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42884184 | PubMed |
| 42575141 | Podocyte dysfunction in kidney diseases: Mechanisms and therapeutic advances. | Sci Prog | 2026 | https://conductscience.org/library/papers/42575141 | PubMed |
| 42224032 | The Weary Gatekeeper: Podocyte Aging and Glomerular Decline. | J Am Soc Nephrol | 2026 | https://conductscience.org/library/papers/42224032 | PubMed |
| 41892341 | Plasminogen Activator Inhibitor 1, Cell Senescence, and Aging-Related Diseases. | Cells | 2026 | https://conductscience.org/library/papers/41892341 | PubMed |
| 41597279 | Targeting SMPDL3B to Ameliorate Radiation- and Cisplatin-Induced Renal Toxicity. | Cells | 2026 | https://conductscience.org/library/papers/41597279 | PubMed |
| 41516293 | miRNA in the Progression of Diabetic Kidney Disease: New Insight. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41516293 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41009719
GET https://conductscience.org/api/papers/v1/41009719/references?page=2